-transparent.png){kind=logo}
A female patient aged 37 years who suffered from chronic myeloid leukemia received an allogeneic bone marrow transplantation (BMT) from an HLA-matched unrelated donor. No life-threatening complications ensued; 2.5 years after BMT she is still in complete remission. Survival after BMT from an unrelated donor for the time being is still lower than that after BMT from a related donor, but is improving due to better prevention and treatment of opportunistic infections and better selection of registered donors by meticulous HLA matching.
Related Publications
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
January 1993,
Bone marrow transplantation,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
January 1993,
Leukemia & lymphoma,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
June 1992,
Seminars in oncology,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
April 1998,
Bone marrow transplantation,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
March 1996,
Current opinion in oncology,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
September 1994,
British journal of haematology,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
February 1987,
Bone marrow transplantation,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
July 1995,
Cancer treatment reviews,
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
January 1991,
European journal of cancer (Oxford, England : 1990),
G S Liem, and
J J Cornelissen, and
M Oudshoorn, and
K Sintnicolaas, and
B Löwenberg, and
A Hagenbeek
December 1991,
Bone marrow transplantation,
